Logo image of MXIM

Maxim Integrated (MXIM) Stock Fundamental Analysis

USA - NASDAQ:MXIM -

103.14
-1.23 (-1.18%)
Last: 8/25/2021, 8:50:07 PM
104.74
+1.6 (+1.55%)
After Hours: 8/25/2021, 8:50:07 PM
Fundamental Rating

3

MXIM gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 112 industry peers in the Semiconductors & Semiconductor Equipment industry. While MXIM seems to be doing ok healthwise, there are quite some concerns on its profitability. MXIM is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

MXIM had positive earnings in the past year.

1.2 Ratios

Industry RankSector Rank
ROA 18.29%
ROE 34.24%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM 35.92%
PM (TTM) 31.42%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

More info and screens

4

2. Health

2.1 Basic Checks

MXIM has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

MXIM has an Altman-Z score of 10.57. This indicates that MXIM is financially healthy and has little risk of bankruptcy at the moment.
A Debt/Equity ratio of 0.41 indicates that MXIM is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.41
Debt/FCF N/A
Altman-Z 10.57
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

A Current Ratio of 5.05 indicates that MXIM has no problem at all paying its short term obligations.
MXIM has a Quick Ratio of 4.68. This indicates that MXIM is financially healthy and has no problem in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 5.05
Quick Ratio 4.68

More info and screens

5

3. Growth

3.1 Past

MXIM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 40.09%, which is quite impressive.
Measured over the past years, MXIM shows a quite strong growth in Earnings Per Share. The EPS has been growing by 14.16% on average per year.
MXIM shows a strong growth in Revenue. In the last year, the Revenue has grown by 20.13%.
Measured over the past years, MXIM shows a small growth in Revenue. The Revenue has been growing by 3.70% on average per year.
EPS 1Y (TTM)40.09%
EPS 3Y5.48%
EPS 5Y14.16%
EPS Q2Q%56.9%
Revenue 1Y (TTM)20.13%
Revenue growth 3Y2.01%
Revenue growth 5Y3.7%
Sales Q2Q%31.99%

3.2 Future

The Earnings Per Share is expected to grow by 5.68% on average over the next years.
Based on estimates for the next years, MXIM will show a small growth in Revenue. The Revenue will grow by 6.05% on average per year.
EPS Next Y10.34%
EPS Next 2Y7.95%
EPS Next 3Y7.64%
EPS Next 5Y5.68%
Revenue Next Year12.48%
Revenue Next 2Y8.64%
Revenue Next 3Y7.36%
Revenue Next 5Y6.05%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
MXIM Yearly Revenue VS EstimatesMXIM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1B 2B 3B
MXIM Yearly EPS VS EstimatesMXIM Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 32.43, the valuation of MXIM can be described as expensive.
The average S&P500 Price/Earnings ratio is at 27.30. MXIM is around the same levels.
A Price/Forward Earnings ratio of 29.40 indicates a quite expensive valuation of MXIM.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.73, MXIM is valued a bit more expensive.
Industry RankSector Rank
PE 32.43
Fwd PE 29.4
MXIM Price Earnings VS Forward Price EarningsMXIM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 25.34
MXIM Per share dataMXIM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)3.14
PEG (5Y)2.29
EPS Next 2Y7.95%
EPS Next 3Y7.64%

More info and screens

4

5. Dividend

5.1 Amount

MXIM has a Yearly Dividend Yield of 1.40%.
Compared to an average S&P500 Dividend Yield of 2.38, MXIM's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.4%

5.2 History

The dividend of MXIM has a limited annual growth rate of 4.42%.
MXIM has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)4.42%
Div Incr YearsN/A
Div Non Decr YearsN/A
MXIM Yearly Dividends per shareMXIM Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 0.5 1 1.5

5.3 Sustainability

15.49% of the earnings are spent on dividend by MXIM. This is a low number and sustainable payout ratio.
MXIM's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP15.49%
EPS Next 2Y7.95%
EPS Next 3Y7.64%
MXIM Dividend Payout.MXIM Dividend Payout, showing the Payout Ratio.MXIM Dividend Payout.PayoutRetained Earnings

More info and screens

Maxim Integrated

NASDAQ:MXIM (8/25/2021, 8:50:07 PM)

After market: 104.74 +1.6 (+1.55%)

103.14

-1.23 (-1.18%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)N/A N/A
Earnings (Next)02-11 2022-02-11/amc
Inst Owners0%
Inst Owner Change-99.49%
Ins Owners0.32%
Ins Owner Change0%
Market Cap27.70B
Analysts68
Price Target99.31 (-3.71%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.4%
Yearly Dividend1.44
Dividend Growth(5Y)4.42%
DP15.49%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 32.43
Fwd PE 29.4
P/S 10.52
P/FCF N/A
P/OCF N/A
P/B 11.47
P/tB N/A
EV/EBITDA 25.34
EPS(TTM)3.18
EY3.08%
EPS(NY)3.51
Fwd EY3.4%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS9.8
BVpS9
TBVpSN/A
PEG (NY)3.14
PEG (5Y)2.29
Profitability
Industry RankSector Rank
ROA 18.29%
ROE 34.24%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 35.92%
PM (TTM) 31.42%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.58
Health
Industry RankSector Rank
Debt/Equity 0.41
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.05
Quick Ratio 4.68
Altman-Z 10.57
F-Score7
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)40.09%
EPS 3Y5.48%
EPS 5Y14.16%
EPS Q2Q%56.9%
EPS Next Y10.34%
EPS Next 2Y7.95%
EPS Next 3Y7.64%
EPS Next 5Y5.68%
Revenue 1Y (TTM)20.13%
Revenue growth 3Y2.01%
Revenue growth 5Y3.7%
Sales Q2Q%31.99%
Revenue Next Year12.48%
Revenue Next 2Y8.64%
Revenue Next 3Y7.36%
Revenue Next 5Y6.05%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A